Actinium Pharmaceuticals, Inc. (ATNM): Cash & Equivalents
$48.00M
As of 2025-12-31
$36.47M
As of 2026-06-30
-23.9%
3-year compound annual growth
-5.5%
5-year compound annual growth
+6.5%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $48.00M | -34.2% | 2026-03-30, Balance as of period end |
| 2024-12-31 | $72.90M | -4.9% | 2026-03-30, Balance as of period end |
| 2023-12-31 | $76.68M | -29.6% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $108.91M | +39.9% | 2024-03-29, Balance as of period end |
| 2021-12-31 | $77.83M | +22.4% | 2023-03-31, Balance as of period end |
| 2020-12-31 | $63.56M | +586.8% | 2022-03-25, Balance as of period end |
| 2019-12-31 | $9.25M | -32.3% | 2021-03-31, Balance as of period end |
| 2018-12-31 | $13.67M | -21.4% | 2020-05-08, Balance as of period end |
| 2017-12-31 | $17.40M | -15.2% | 2019-03-15, Balance as of period end |
| 2016-12-31 | $20.52M | -20.0% | 2019-03-15, Balance as of period end |
| 2015-12-31 | $25.64M | +282.3% | 2018-03-16, Balance as of period end |
| 2014-12-31 | $6.71M | +21.2% | 2017-03-16, Balance as of period end |
| 2013-12-31 | $5.53M | -1.5% | 2016-03-11, Balance as of period end |
| 2012-12-31 | $5.62M | -1.5% | 2014-02-28, Balance as of period end |
| 2011-12-31 | $5.70M | n/m | 2014-02-28, Balance as of period end |
| 2010-12-31 | $196.1K | n/a | 2014-02-28, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $48.00M | -34.2% |
| Incannex Healthcare Inc. (IXHL) | 2025-06-30 | $15.04M | +156.7% |
| iBio, Inc. (IBIO) | 2026-06-30 | $56.40M | +557.1% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $4.75M | +21.6% |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $2.18M | -59.8% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $44.27M | -32.7% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $38.34M | -51.0% |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | $3.06M | -16.8% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $15.86M | -88.2% |
Compare ATNM, IXHL, IBIO, SILO side by side · Screen every company in Pharmaceutical Preparations ↗